Status:
COMPLETED
HEMOCC Study. Hemostasis in Cirrhotic Children.
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Esophageal and Gastric Varices
Child, Only
Eligibility:
All Genders
4-50 years
Phase:
NA
Brief Summary
Prospective investigations into the role of hemostatic factors in the risk of variceal bleeding among children with chronic liver disease (thromboelastometry e.g) is still required. A better understan...
Detailed Description
The investigators aim to start a prospective and observational study over a 2 years period. First, the investigators will identify all children suffering from cirrhosis irrespective of underlying eti...
Eligibility Criteria
Inclusion
- Children suffering from decompensated cirrhosis and needing an orthotopic liver transplantation
- Children suffering from a compensated cirrhosis (compensated cirrhosis with kasai surgery in biliary atresia patients e.g) or from portal hypertension without cirrhosis (portal vein thrombosis e.g)
- Each patient will have a comprehensive assessment of portal hypertension (abdominal US-Doppler and upper gastrointestinal endoscopy) and hemostasis
Exclusion
- No underlying disease which can alter hemostasis (hemophilia, sepsis…)
- No medication which can alter hemostasis (aspirin, anti-inflammatory drugs,…)
Key Trial Info
Start Date :
October 18 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03244332
Start Date
October 18 2013
End Date
July 15 2017
Last Update
August 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint-Luc
Brussels, Belgium, 1200